Cargando…
Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a re...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867780/ https://www.ncbi.nlm.nih.gov/pubmed/35209946 http://dx.doi.org/10.1186/s40478-022-01326-7 |
_version_ | 1784656123909898240 |
---|---|
author | Lee, Bongyong Mohamad, Iqbal Pokhrel, Rudramani Murad, Rabi Yuan, Menglang Stapleton, Stacie Bettegowda, Chetan Jallo, George Eberhart, Charles G. Garrett, Timothy Perera, Ranjan J. |
author_facet | Lee, Bongyong Mohamad, Iqbal Pokhrel, Rudramani Murad, Rabi Yuan, Menglang Stapleton, Stacie Bettegowda, Chetan Jallo, George Eberhart, Charles G. Garrett, Timothy Perera, Ranjan J. |
author_sort | Lee, Bongyong |
collection | PubMed |
description | Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a relatively non-invasive means for disease diagnosis. There has yet to be an integrated analysis of the transcriptomic, metabolomic, and lipidomic changes occurring in the CSF of children with MB. CSF samples from patients with (n = 40) or without (n = 11; no cancer) MB were subjected to RNA-sequencing and high-resolution mass spectrometry to identify RNA, metabolite, and lipid profiles. Differentially expressed transcripts, metabolites, and lipids were identified and their biological significance assessed by pathway analysis. The DIABLO multivariate analysis package (R package mixOmics) was used to integrate the molecular changes characterizing the CSF of MB patients. Differentially expressed transcripts, metabolites, and lipids in CSF were discriminatory for the presence of MB but not the exact molecular subtype. One hundred and ten genes and ten circular RNAs were differentially expressed in MB CSF compared with normal, representing TGF-β signaling, TNF-α signaling via NF-kB, and adipogenesis pathways. Tricarboxylic acid cycle and other metabolites (malate, fumarate, succinate, α-ketoglutarate, hydroxypyruvate, N-acetyl-aspartate) and total triacylglycerols were significantly upregulated in MB CSF compared with normal CSF. Although separating MBs into subgroups using transcriptomic, metabolomic, and lipid signatures in CSF was challenging, we were able to identify a group of omics signatures that could separate cancer from normal CSF. Metabolic and lipidomic profiles both contained indicators of tumor hypoxia. Our approach provides several candidate signatures that deserve further validation, including the novel circular RNA circ_463, and insights into the impact of MB on the CSF microenvironment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01326-7. |
format | Online Article Text |
id | pubmed-8867780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88677802022-02-25 Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs Lee, Bongyong Mohamad, Iqbal Pokhrel, Rudramani Murad, Rabi Yuan, Menglang Stapleton, Stacie Bettegowda, Chetan Jallo, George Eberhart, Charles G. Garrett, Timothy Perera, Ranjan J. Acta Neuropathol Commun Research Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a relatively non-invasive means for disease diagnosis. There has yet to be an integrated analysis of the transcriptomic, metabolomic, and lipidomic changes occurring in the CSF of children with MB. CSF samples from patients with (n = 40) or without (n = 11; no cancer) MB were subjected to RNA-sequencing and high-resolution mass spectrometry to identify RNA, metabolite, and lipid profiles. Differentially expressed transcripts, metabolites, and lipids were identified and their biological significance assessed by pathway analysis. The DIABLO multivariate analysis package (R package mixOmics) was used to integrate the molecular changes characterizing the CSF of MB patients. Differentially expressed transcripts, metabolites, and lipids in CSF were discriminatory for the presence of MB but not the exact molecular subtype. One hundred and ten genes and ten circular RNAs were differentially expressed in MB CSF compared with normal, representing TGF-β signaling, TNF-α signaling via NF-kB, and adipogenesis pathways. Tricarboxylic acid cycle and other metabolites (malate, fumarate, succinate, α-ketoglutarate, hydroxypyruvate, N-acetyl-aspartate) and total triacylglycerols were significantly upregulated in MB CSF compared with normal CSF. Although separating MBs into subgroups using transcriptomic, metabolomic, and lipid signatures in CSF was challenging, we were able to identify a group of omics signatures that could separate cancer from normal CSF. Metabolic and lipidomic profiles both contained indicators of tumor hypoxia. Our approach provides several candidate signatures that deserve further validation, including the novel circular RNA circ_463, and insights into the impact of MB on the CSF microenvironment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01326-7. BioMed Central 2022-02-24 /pmc/articles/PMC8867780/ /pubmed/35209946 http://dx.doi.org/10.1186/s40478-022-01326-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lee, Bongyong Mohamad, Iqbal Pokhrel, Rudramani Murad, Rabi Yuan, Menglang Stapleton, Stacie Bettegowda, Chetan Jallo, George Eberhart, Charles G. Garrett, Timothy Perera, Ranjan J. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs |
title | Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs |
title_full | Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs |
title_fullStr | Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs |
title_full_unstemmed | Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs |
title_short | Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs |
title_sort | medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific rnas |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867780/ https://www.ncbi.nlm.nih.gov/pubmed/35209946 http://dx.doi.org/10.1186/s40478-022-01326-7 |
work_keys_str_mv | AT leebongyong medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT mohamadiqbal medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT pokhrelrudramani medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT muradrabi medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT yuanmenglang medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT stapletonstacie medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT bettegowdachetan medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT jallogeorge medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT eberhartcharlesg medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT garretttimothy medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas AT pereraranjanj medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas |